Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation.

[This corrects the article DOI: 10.1371/journal.pone.0061939.].

Bibliographic Details
Main Authors: Yueh-Lun Lee, Chih-Wei Chen, Fu-Hwa Liu, Yu-Wen Huang, Huei-Mei Huang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5636156?pdf=render
Description
Summary:[This corrects the article DOI: 10.1371/journal.pone.0061939.].
ISSN:1932-6203

Similar Items